Pharmaceutical

Recursion and Exscientia merge to form drug discovery company

Recursion has signed an agreement to merge with Exscientia to create a global technology-enabled drug discovery company.

Aug 11, 2024 - 04:00
Recursion and Exscientia merge to form drug discovery company
Recursion has signed an agreement to merge with Exscientia to create a global technology-enabled drug discovery company.
Read the original article

Tags:

Previous Article

Momentum Biotechnologies and Cube Biotech link for therapeutic solutions

Next Article

Brain electrical stimulation suppresses appetite. A new frontier in obesity trea...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA approves import of French drug for syphilis amidst wider drug shortages

FDA approves import of French drug for syphilis amidst ...

Jan 11, 2024

STAT+: Pharmalittle: CVS to overhaul how it’s paid for drugs; Biden drug-shortage plan won’t expand chemo supplies

STAT+: Pharmalittle: CVS to overhaul how it’s paid for ...

Dec 5, 2023

STAT+: A young boy’s nightmare diagnosis, and the $3 million one-time treatment that will likely save his life

STAT+: A young boy’s nightmare diagnosis, and the $3 mi...

Apr 3, 2023